Avalo Therapeutics Purchases Optional Milestone Buyout

AI Briefing

• – Avalo Therapeutics enters into milestone buyout option agreement with AlmataBio.
• – The agreement is related to the company's prior acquisition of AlmataBio in March 2024.
• – Details of the agreement were not disclosed.